Copan FecalSwab® receives the 510(k) FDA clearance for molecular use with the BD MAX™ Enteric & Extended Enteric Bacterial Panels

Copan announces the 510(k) FDA clearance of its Copan FecalSwab® for collecting and transporting stool samples to be processed with BD Enteric Bacterial Panel and BD Extended Enteric Bacterial Panel on the BD MAX™ System. This clearance opens new molecular diagnostic opportunities for customers who already use FecalSwab® to maintain enteric pathogens’ vitality for microbial culturing.

Download